4.5 Article

Intraoperative delineation of primary brain tumors using time-resolved fluorescence spectroscopy

Journal

JOURNAL OF BIOMEDICAL OPTICS
Volume 15, Issue 2, Pages -

Publisher

SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
DOI: 10.1117/1.3374049

Keywords

glioma; time resolved; fluorescence; spectroscopy; intraoperative; autofluorescence

Funding

  1. Whitaker Foundation [RG-01-0346]
  2. Maxine-Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center
  3. University of Southern California

Ask authors/readers for more resources

The goal of this study is to determine the potential of time-resolved laser-induced fluorescence spectroscopy (TR-LIFS) as an adjunctive tool for delineation of brain tumor from surrounding normal tissue in order to assist the neurosurgeon in near-complete tumor excision. A time-domain TR-LIFS prototype apparatus (gated photomultiplier detection, fast digitizer) was used for recording tissue autofluorescence in normal cortex (NC), normal white matter (NWM), and various grades of gliomas intraoperatively. Tissue fluorescence was induced with a pulsed nitrogen laser (337 nm, 700 ps), and the intensity decay profiles were recorded in the 360- to 550-nm spectral range (10-nm interval). Histopathological analysis (hematoxylin & eosin) of the biopsy samples taken from the site of TR-LIFS measurements was used for validation of spectroscopic results. Preliminary results on 17 patients demonstrate that normal cortex (N=16) and normal white matter (N=3) show two peaks of fluorescence emission at 390 nm (lifetime=1.8 +/- 0.3 ns) and 460 nm (lifetime=0.8 +/- 0.1 ns). The 390-nm emission peak is absent in low-grade glioma (N=5; lifetime=1.1 ns) and reduced in high-grade glioma (N=9; lifetime=1.7 +/- 0.4 ns). The emission characteristics at 460 nm in all tissues correlated with the nicotinamide adenine dinucleotide fluorescence (peak: 440 to 460 nm; lifetime: 0.8 to 1.0 ns). These findings demonstrate the potential of using TR-LIFS as a tool for enhanced delineation of brain tumors during surgery. In addition, this study evaluates similarities and differences between TR-LIFS signatures of brain tumors obtained in vivo and those previously reported in ex vivo brain tumor specimens. (C) 2010 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3374049]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Intraoperative detection of IDH-mutant glioma using fluorescence lifetime imaging

Silvia Noble Anbunesan, Alba Alfonso-Garcia, Xiangnan Zhou, Julien Bec, Han Sung Lee, Lee-Way Jin, Orin Bloch, Laura Marcu

Summary: Intraoperative identification of IDH-mutant glioma using fluorescence lifetime imaging can aid in modifying tumor resection strategies for better survival outcomes.

JOURNAL OF BIOPHOTONICS (2023)

Article Multidisciplinary Sciences

Activated T cell therapy targeting glioblastoma cancer stem cells

Ken Miyaguchi, Hongqiang Wang, Keith L. Black, Stephen L. Shiao, Rongfu Wang, John S. Yu

Summary: Efficient activation of T cells with tumor-associated antigens (TAAs) to glioblastoma (GBM) stem cells was achieved through the use of three different antigen sources loaded onto dendritic cells (DCs). An activated T cell (ATC) protocol was developed and optimized for a phase I clinical trial to target GSCs. The synthetic peptide pool loading method showed significantly increased cytotoxicity towards target cells.

SCIENTIFIC REPORTS (2023)

Article Clinical Neurology

Retinal pathological features and proteome signatures of Alzheimer's disease

Yosef Koronyo, Altan Rentsendorj, Nazanin Mirzaei, Giovanna C. Regis, Julia Sheyn, Haoshen Shi, Ernesto Barron, Galen Cook-Wiens, Anthony R. Rodriguez, Rodrigo Medeiros, Joao A. Paulo, Veer B. Gupta, Andrei A. Kramerov, Alexander V. Ljubimov, Jennifer E. Van Eyk, Stuart L. Graham, Vivek K. Gupta, John M. Ringman, David R. Hinton, Carol A. Miller, Keith L. Black, Antonino Cattaneo, Giovanni Meli, Mehdi Mirzaei, Dieu-Trang Fuchs, Maya Koronyo-Hamaoui

Summary: Pathologies of Alzheimer’s disease (AD) can be found in the neurosensory retina, but their exact nature and distribution in relation to disease progression in the brain are still largely unknown. This study conducted extensive histopathological and biochemical investigations of postmortem retina and brain tissues from 86 human donors to better understand the pathological features of AD in the retina. The findings suggest a quantitative relationship between retinopathy, brain pathology, and cognitive impairment, and may lead to the development of reliable retinal biomarkers for noninvasive screening and monitoring of AD.

ACTA NEUROPATHOLOGICA (2023)

Article Clinical Neurology

Retinal arterial Aβ40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients

Haoshen Shi, Yosef Koronyo, Dieu-Trang Fuchs, Julia Sheyn, Ousman Jallow, Krishna Mandalia, Stuart L. Graham, Vivek K. Gupta, Mehdi Mirzaei, Andrei A. Kramerov, Alexander V. Ljubimov, Debra Hawes, Carol A. Miller, Keith L. Black, Roxana O. Carare, Maya Koronyo-Hamaoui

Summary: This study found that vascular amyloid beta (Aβ) protein deposits were detected in retinas of mild cognitively impaired (MCI) and Alzheimer's disease (AD) patients, and these deposits were linked to disease status. The study also revealed that the components of retinal vascular tight junctions (TJs) and Aβ expression were correlated with neuropathology. The severe decreases in retinal vascular zonula occludens-1 (ZO-1) and claudin-5 were identified in MCI and AD patients, which correlated with arteriolar Aβ(40) deposition and cerebral pathology and cognitive deficits.

ALZHEIMERS & DEMENTIA (2023)

Article Biochemistry & Molecular Biology

Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1

Ryan Cordner, Michelle Jhun, Akanksha Panwar, HongQiang Wang, Nicole Gull, Ramachandran Murali, Joseph H. McAbee, Armen Mardiros, Akane Sanchez-Takei, Mia W. Mazer, Xuemo Fan, Emmanuel Jouanneau, John S. Yu, Keith L. Black, Christopher J. Wheeler

Summary: The efficacy of cancer immunotherapy in treating highly malignant tumors like glioblastoma multiforme can be improved by exploiting endogenous immune enhancers among mutated cancer genes. Isocitrate Dehydrogenase-1 (IDH1), commonly mutated in gliomas, enhances glioma vaccine efficacy and can distinguish long-term survivors from short-term survivors in GBM patients. IDH1 enhances T cell responses to tumor antigens and increases glioma cell lysis, while mutant IDH1R132H lacks these effects and decreases host survival after immunotherapy. This discovery uncovers a new axis for immunotherapeutic improvement in GBM and other cancers and reveals novel functions of IDH1, indicating a direct link between lytic T cell function and metabolic activity in target cells.

ONCOGENE (2023)

Review Physiology

The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition

Ron Danziger, Dieu-Trang Fuchs, Yosef Koronyo, Altan Rentsendorj, Julia Sheyn, Eric Y. Y. Hayden, David B. B. Teplow, Keith L. L. Black, Sebastien Fuchs, Kenneth E. E. Bernstein, Maya Koronyo-Hamaoui

Summary: This review discusses the role of angiotensin-converting enzyme (ACE) in Alzheimer's disease (AD) and its potential as a therapeutic target. ACE has been found to degrade the neurotoxic peptide amyloid beta-protein (Aβ(42)), which is associated with AD. Previous studies have shown that overexpression of ACE in myelomonocytic cells improves immune responses and reduces viral and bacterial infection, tumor growth, and atherosclerotic plaque in mice. In a murine model of AD, introducing ACE-expressing myelomonocytes diminished neuropathology and improved cognitive functions through ACE catalytic activity. The therapeutic effects can be achieved by enhancing ACE expression in bone marrow-derived monocytes alone, without targeting central nervous system resident microglia. These findings suggest the potential for utilizing ACE as a natural mechanism to ameliorate AD pathogenesis.

FRONTIERS IN PHYSIOLOGY (2023)

Article Immunology

Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis

Altan Rentsendorj, Koen Raedschelders, Dieu-Trang Fuchs, Julia Sheyn, Vineet Vaibhav, Rebecca A. Porritt, Haoshen Shi, Jargalsaikhan Dagvadorj, Juliana de Freitas Germano, Yosef Koronyo, Moshe Arditi, Keith L. Black, Bhakta Prasad Gaire, Jennifer E. Van Eyk, Maya Koronyo-Hamaoui

Summary: The expression of OPN in macrophages regulates their inflammatory state and protein synthesis. In OPN-deficient macrophages, protein metabolism disruption and apoptosis occur, whereas GA stimulation restores protein synthesis and cellular homeostasis in macrophages.

FRONTIERS IN IMMUNOLOGY (2023)

Review Engineering, Manufacturing

Ultrafast Laser Additive Manufacturing: A Review

Jacob Saunders, Mohammad Elbestawi, Qiyin Fang

Summary: Ultrafast lasers have been proven to be evolving manufacturing tools, and additive manufacturing has emerged as a key area for 3D fabrication of objects with arbitrary geometries. The use of ultrafast lasers in additive manufacturing presents possibilities for next-generation manufacturing techniques, particularly for hard-to-process materials, transparent materials, and micro- and nano-manufacturing. This review provides an overview of the development, applications, and recent advancements of selective laser melting/sintering, multiphoton lithography, laser-induced forward transfer, pulsed laser deposition, and welding, as well as the progress in process advancements such as process monitoring and control, increased throughput, and integration into hybrid manufacturing systems.

JOURNAL OF MANUFACTURING AND MATERIALS PROCESSING (2023)

Editorial Material Engineering, Electrical & Electronic

Editorial Introduction to JSTQE Special Issue on Biophotonics (2023)

Qiyin Fang, Charles Kervrann, David Nolte, Oxana Semyachkina-Glushkovskaya, Shuo Tang, Yuji Matsuura, Zachary Smith

Summary: Biophotonics is an interdisciplinary field that combines photonics and biomedical applications. It has made significant advancements in clinical diagnosis, therapeutics, biotechnology, and environmental studies. The integration of optics and biology has led to quick adoption of photonics technologies in medicine due to its compatibility with minimally invasive procedures.

IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS (2023)

Article Chemistry, Multidisciplinary

13-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models

Liron L. Israel, Tao Sun, Oliver Braubach, Alysia Cox, Ekaterina S. Shatalova, Harun-Mohammad Rashid, Anna Galstyan, Zachary Grodzinski, Xue Ying Song, Oksana Chepurna, Vladimir A. Ljubimov, Antonella Chiechi, Sachin Sharma, Connor Phebus, Yizhou Wang, Julia Y. Ljubimova, Keith L. Black, Eggehard Holler

Summary: Delivery of therapeutic substances to the brain is challenging due to the blood-brain barrier, limited stability, and distribution in brain tissue. However, a study demonstrated efficient delivery of microRNA and antisense RNA specifically to neurons using a biodegradable, amphiphilic, and multivalent platform conjugated with a D3-peptide. This targeting approach, through the transcytosis pathway, shows promise in Alzheimer's disease mouse models.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Neurosciences

Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study

Liron L. Israel, Oliver Braubach, Ekaterina S. Shatalova, Oksana Chepurna, Sachin Sharma, Dmytro Klymyshyn, Anna Galstyan, Antonella Chiechi, Alysia Cox, David Herman, Bishop Bliss, Irene Hasen, Amanda Ting, Rebecca Arechavala, Michael T. Kleinman, Rameshwar Patil, Eggehard Holler, Julia Y. Ljubimova, Maya Koronyo-Hamaoui, Tao Sun, Keith L. Black

Summary: In this study using an AD mouse model, the effects of different sized particulate matter from polluted air on Alzheimer's disease development were investigated. The results showed that exposure to airborne PM caused significant dysregulation in the brain transcriptome and accelerated Alzheimer's-related pathology.

NEUROBIOLOGY OF DISEASE (2023)

Article Chemistry, Multidisciplinary

Characterizing Mineral Ellipsoids in New Bone Formation at the Interface of Ti6Al4V Porous Implants

Joseph Deering, Jianyu Chen, Dalia Mahmoud, Tengteng Tang, Yujing Lin, Qiyin Fang, Gregory R. Wohl, Mohamed Elbestawi, Kathryn Grandfield

Summary: The newly formed bone structure contains disorder within an ordered multiscale structure from macro to nanoscale. The heterogeneity in mineral ellipsoid packing at the interface of porous titanium implants is characterized using electron microscopy. The ellipsoids within the bone tissue exhibit alternating orientations corresponding to unique lamellar packets near the titanium implant interface, with short-order ellipsoid orientation shifts observed in the 3D probe.

ADVANCED MATERIALS INTERFACES (2023)

Meeting Abstract Oncology

Brain delivery of clinically suitable nanobioconjugates to inhibit glioblastoma growth through extracellular matrix-immune cell crosstalk

Alexander V. Ljubimov, Rameshwar Patil, Hui Ding, Liron Israel, Eggehard Holler, Julia Y. Ljubimova, Tao Sun, Keith L. Black

CANCER RESEARCH (2023)

Article Oncology

The Role of Cellular Immunity and Adaptive Immunity in Pathophysiology of Brain and Spinal Cord Tumors

Angelique Sao-Mai S. Tay, Keith L. Black, John S. Yu

Summary: Significant progress has been made in understanding CNS tumors, particularly glioma, but survival rates for malignant glioma patients remain low. Despite advances in radiation and chemotherapy, glioblastoma multiforme (GBM) still has one of the worst 5-year survival rates among all cancers. This chapter reviews the immune system's dysfunction in the tumor microenvironment, identifying potential targets for therapy and discussing current immunotherapy treatment strategies. Additionally, glioma is characterized as a subset of primary spinal cord tumors, and treatment recommendations are outlined.

HUMAN BRAIN AND SPINAL CORD TUMORS: FROM BENCH TO BEDSIDE, VOL. 1: Neuroimmunology and Neurogenetics (2023)

Article Clinical Neurology

ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation

George K. Hanna, Mecca Madany, Angelique Sao-Mai Sy Tay, Lincoln A. Edwards, Sungjin Kim, Justin S. Michael, Miriam Nuno, Tom Thomas, Aiguo Li, Dror Berel, Keith L. Black, Xuemo Fan, Wei Zhang, Jeremy D. Rudnick, Rongfu Wang, John S. Yu

Summary: The study explores the role of transcription factor ZEB1 in therapeutic resistance to radiation and chemotherapy in glioblastoma. The loss of ZEB1 leads to increased resistance, while overexpression of ZEB1 increases sensitivity. This study uncovers a potential targetable cell surface receptor in these resistant cells.

JOURNAL OF NEUROSURGERY (2023)

No Data Available